DK170162B1 - Thiazolderivater og fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne - Google Patents

Thiazolderivater og fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne Download PDF

Info

Publication number
DK170162B1
DK170162B1 DK128688A DK128688A DK170162B1 DK 170162 B1 DK170162 B1 DK 170162B1 DK 128688 A DK128688 A DK 128688A DK 128688 A DK128688 A DK 128688A DK 170162 B1 DK170162 B1 DK 170162B1
Authority
DK
Denmark
Prior art keywords
group
dihydrochloride
hydrogen
alkyl group
alkyl
Prior art date
Application number
DK128688A
Other languages
Danish (da)
English (en)
Other versions
DK128688A (da
DK128688D0 (da
Inventor
Kathleen Biziere
Dominique Olliero
Paul Worms
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK128688D0 publication Critical patent/DK128688D0/da
Publication of DK128688A publication Critical patent/DK128688A/da
Application granted granted Critical
Publication of DK170162B1 publication Critical patent/DK170162B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
DK128688A 1987-03-12 1988-03-09 Thiazolderivater og fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne DK170162B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8703398 1987-03-12
FR8703398A FR2612187B1 (fr) 1987-03-12 1987-03-12 Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant

Publications (3)

Publication Number Publication Date
DK128688D0 DK128688D0 (da) 1988-03-09
DK128688A DK128688A (da) 1988-09-13
DK170162B1 true DK170162B1 (da) 1995-06-06

Family

ID=9348897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK128688A DK170162B1 (da) 1987-03-12 1988-03-09 Thiazolderivater og fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne

Country Status (27)

Country Link
EP (1) EP0283390B1 (de)
JP (1) JPS63243080A (de)
KR (1) KR880011135A (de)
AR (1) AR243515A1 (de)
AT (1) ATE86249T1 (de)
AU (1) AU612350B2 (de)
DD (1) DD274028A5 (de)
DE (1) DE3878708T2 (de)
DK (1) DK170162B1 (de)
ES (1) ES2053778T3 (de)
FI (1) FI881152A (de)
FR (1) FR2612187B1 (de)
HU (1) HU198916B (de)
IE (1) IE60173B1 (de)
IL (1) IL85704A (de)
MA (1) MA21207A1 (de)
MY (1) MY103233A (de)
NO (1) NO170081C (de)
NZ (1) NZ223845A (de)
OA (1) OA08871A (de)
PH (1) PH25389A (de)
PL (1) PL151889B1 (de)
PT (1) PT86952B (de)
SU (1) SU1604157A3 (de)
TN (1) TNSN88020A1 (de)
YU (1) YU49688A (de)
ZA (1) ZA881764B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6440474A (en) * 1987-08-04 1989-02-10 Hisamitsu Pharmaceutical Co Novel 2-substituted aminothiazole derivative
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
WO1992021666A1 (fr) * 1991-05-31 1992-12-10 Laboratoires Upsa Derives de thiazole antagonistes de recepteurs a l'angiotensine ii
FR2677021B1 (fr) * 1991-05-31 1993-10-01 Upsa Laboratoires Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
WO1994020476A1 (en) * 1993-03-02 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Novel heterocyclic compound
FR2714059B1 (fr) * 1993-12-21 1996-03-08 Sanofi Elf Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
FR2735777B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2754258B1 (fr) * 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
GB9705428D0 (en) * 1997-03-15 1997-04-30 Knoll Ag Therapeutic agents
JP2002518380A (ja) * 1998-06-18 2002-06-25 ブリストル−マイヤーズ スクイブ カンパニー サイクリン依存キナーゼの炭素置換アミノチアゾール抑制剤
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
WO2000064880A1 (en) 1999-04-22 2000-11-02 Synaptic Pharmaceutical Corporation Selective npy (y5) antagonists
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
WO2003061655A1 (en) * 2002-01-16 2003-07-31 University Of Virginia Patent Foundation 2-aminothiazole allosteric enhancers of a1 adenosine receptors
DE10251513A1 (de) * 2002-11-04 2004-05-19 Basf Ag Übergangsmetallkatalysatoren für (Co)Polymerisation von olefinischen Monomeren
JP2007261945A (ja) * 2004-04-07 2007-10-11 Taisho Pharmaceut Co Ltd チアゾール誘導体
EP1904491A2 (de) * 2005-05-31 2008-04-02 Vertex Pharmaceuticals Incorporated Als modulatoren von ionenkanälen geeignete heterocyclen
KR20110137941A (ko) * 2010-06-18 2011-12-26 (주) 에빅스젠 신규한 티오우레아 또는 우레아 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 ａｉｄｓ 예방 또는 치료용 약학 조성물
RU2456284C1 (ru) * 2011-04-12 2012-07-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" 2-аминопропилморфолино-5-арил-6н-1,3,4-тиадиазины, дигидробромиды и 2-аминопропилморфолино-4-арилтиазолы, гидробромиды, обладающие антиагрегантным действием
JP6698083B2 (ja) * 2014-11-10 2020-05-27 エヴリース・バイオ, エルエルシーEvrys Bio, LLC 抗ｈｃｍｖの組成物及び方法
CN115160207B (zh) * 2022-04-21 2023-09-26 烟台大学 苯甲酰硫脲类化合物及其制备方法和赤潮藻杀藻剂的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2975182A (en) * 1959-11-16 1961-03-14 Paul A J Janssen 1-(aroylalkyl)-4-(heterocyclyl) piperazines
FR2092714B1 (de) * 1970-06-11 1974-03-22 Melle Bezons
CH583232A5 (de) * 1973-02-02 1976-12-31 Wander Ag Dr A
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
NL8601494A (nl) * 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.

Also Published As

Publication number Publication date
JPS63243080A (ja) 1988-10-07
FR2612187B1 (fr) 1989-07-21
TNSN88020A1 (fr) 1990-07-10
EP0283390A3 (en) 1988-09-28
KR880011135A (ko) 1988-10-26
YU49688A (en) 1989-10-31
DE3878708T2 (de) 1993-09-02
ATE86249T1 (de) 1993-03-15
FI881152A (fi) 1988-09-13
HU198916B (en) 1989-12-28
MA21207A1 (fr) 1988-10-01
NO881093D0 (no) 1988-03-11
PL151889B1 (en) 1990-10-31
DD274028A5 (de) 1989-12-06
EP0283390A2 (de) 1988-09-21
NO170081B (no) 1992-06-01
ZA881764B (en) 1988-08-31
NO881093L (no) 1988-09-13
IE880721L (en) 1988-09-12
DK128688A (da) 1988-09-13
MY103233A (en) 1993-05-29
PH25389A (en) 1991-06-03
FI881152A0 (fi) 1988-03-11
DK128688D0 (da) 1988-03-09
IL85704A (en) 1992-11-15
IE60173B1 (en) 1994-06-15
SU1604157A3 (ru) 1990-10-30
IL85704A0 (en) 1988-08-31
ES2053778T3 (es) 1994-08-01
AU612350B2 (en) 1991-07-11
AU1266288A (en) 1988-09-15
DE3878708D1 (de) 1993-04-08
PT86952A (pt) 1988-04-01
NO170081C (no) 1992-09-09
NZ223845A (en) 1990-11-27
HUT47261A (en) 1989-02-28
PT86952B (pt) 1992-05-29
AR243515A1 (es) 1993-08-31
OA08871A (fr) 1989-10-31
PL271132A1 (en) 1988-11-24
EP0283390B1 (de) 1993-03-03
FR2612187A1 (fr) 1988-09-16

Similar Documents

Publication Publication Date Title
DK170162B1 (da) Thiazolderivater og fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
JP2921578B2 (ja) ピペリジン化合物およびその製造方法およびその用途
US4472403A (en) Quinoline derivatives and pharmaceutical compositions and methods for treating cardiovascular disease with such compounds
US4711899A (en) 2-(4-benzoyl-1-piperidyl)-1-phenylalkanol derivatives
JP2002509918A (ja) ムスカリン性レセプタに活性を有する化合物
PL186204B1 (pl) Pochodne 5-fenylo-3-(piperydyn-4-ylo)-1,3,4-oksadiazol-2(3H)-onu do stosowania jako ligandy receptora 5-HT lub H
CA2549651A1 (en) Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
US5021420A (en) Derivatives of (AZA)naphthalenesultam, their preparation and compositions containing them
GB1588166A (en) Nitrogen-containing heterocyclic compounds
CA2503713A1 (en) Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
PT97700B (pt) Processo de preparacao de agentes terapeuticos anti-diabeticos
US3767653A (en) Thiazines
IE920095A1 (en) Heterocyclic hydroxylamines
WO1993010742A2 (en) Chemical compounds, their preparation and use
EP0612730A1 (de) Morphinan-O-Arylether
HUT51245A (en) Process for production of derivatives of amidin and medical compositions containing such active substances
DK162220B (da) Tricykliske pyridazinderivater, som er agonister af cholinerge receptorer, fremgangsmaade til fremstilling af derivaterne, og laegemidler, hvori de er til stede
ES2226726T3 (es) Tetrahidroquinazolina-2,4-diona y usos terapeuticos de la misma.
US5300515A (en) Carbamic acid derivatives and method for preparing the same
US4447439A (en) 2-Cyclic amino-2-(1,2-benzisoxazol-3-yl)acetic acid ester derivatives, process for the preparation thereof and composition containing the same
US5378714A (en) Antipsychotic piperidine derivatives
AU630085B2 (en) 4,5,6,7-tetrahydro isothiazolo (4,5-c) pyridine derivatives
US5574033A (en) Heterocyclic compound and cardiotonic agent containing the same as effective component
US4711889A (en) Schistosomicidal acridanone hydrazones
JPS6212757A (ja) 桂皮酸アミド誘導体

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed